The deal expands its portfolio of life sciences tools.
Germany's Merck KGaA Swoops In With $11.3 Billion Medtech Buyout
Licensing
09:48 AM ET 06/25/2026
Germany's Merck KGaA pledged Thursday to buy Bio-Techne (TECH) for $11.3 billion. The deal expands its portfolio of reagents, life sciences tools and diagnostic products. Bio-Techne stock rocketed more than 19% to 70.29, approaching the deal price of $73 per share. That price tag is a 36% premium to the stock's one-month volume-weighted average trading price, the companies said in…
Bio-Techne Stock Soars as Germany’s Merck to Buy Biotech Company for $11.3 Billion
Germany's Merck to buy Bio-Techne for $11.3 billion
Why Is Bio-Techne Stock Soaring Thursday? - Bio-Techne (NASDAQ:TECH), MERCK KGAA by Merck KGaA (OTC:MKGAF
Merck KGaA throws down $11.3B for Bio-Techne in its biggest deal since 2015 Sigma-Aldrich buy
Merck: Übernahme von Bio-Techne für fast 10 Milliarden Euro
Bio-Techne: Merck kauft Bio-Techne für 11,3 Milliarden Dollar
Übernahme: Merck kauft US-Laborausrüster für 9,9 Milliarden
Pharma: Merck stärkt Life-Science-Sparte mit US-Milliardenzukauf
Merck: Dieser Pharmakonzern baut die Werkzeuge für die nächste Revolution
Healthcare Stocks Rise Amid M&A Activity — Healthcare Roundup
Bio-Techne stock jumps, with Germany’s Merck KGaA buying the company at a 24% premium.
Merck KGaA has agreed to acquire biotech firm Bio-Techne for $11.3 billion, the German science and healthcare firm said in…
Merck KGaA is acquiring Bio-Techne in an $11.3B all-cash deal to expand its life science, diagnostics, and bioprocessing…
With Merck KGaA’s former electronics business lead Kai Beckmann now at the helm of the entire conglomerate, the new CEO is making…
Merck setzt im Laborgeschäft zum großen Sprung an. Der Dax-Konzern kauft den US-Life-Science-Spezialisten Bio‑Techne für fast 10…
Der Darmstädter Merck-Konzern kauft den US-Laborausrüster Bio-Techne für 11,3 Milliarden Dollar. Der Deal stärkt das…
